OCUSERT PILO-20 Drug Patent Profile
✉ Email this page to a colleague
When do Ocusert Pilo-20 patents expire, and what generic alternatives are available?
Ocusert Pilo-20 is a drug marketed by Epic Pharma Llc and is included in one NDA.
The generic ingredient in OCUSERT PILO-20 is pilocarpine. There are twelve drug master file entries for this compound. Additional details are available on the pilocarpine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OCUSERT PILO-20?
- What are the global sales for OCUSERT PILO-20?
- What is Average Wholesale Price for OCUSERT PILO-20?
Summary for OCUSERT PILO-20
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 58 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,016 |
| DailyMed Link: | OCUSERT PILO-20 at DailyMed |
Recent Clinical Trials for OCUSERT PILO-20
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Florida | Phase 1 |
US Patents and Regulatory Information for OCUSERT PILO-20
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epic Pharma Llc | OCUSERT PILO-20 | pilocarpine | INSERT, EXTENDED RELEASE;OPHTHALMIC | 017431-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
